None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pregnant females who are willing to give written informed consent to participate in the study. 2. Pregnant females of age group 21-35 years with a singleton pregnancy and with a gestation age of 18-19 weeks.
Exclusion criteria
Exclusion criteria: 1. Pregnant females who are unable or unwilling to give written informed consent. 2. Fetal abnormalities in the current or previous pregnancy 3. History of recurrent miscarriage 4. History of pre-eclampsia 5. History of hypertension 6. Twin pregnancy 7. Chronic kidney and liver disease 8. History of malignancy 9. Known case of osteomalacia 10. Recent history of therapeutic vitamin D3 consumption other than supplementation in the study 11. History of seizures 12. Known case of Diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre-eclampsia assessment by blood pressure & proteinuriaTimepoint: Baseline 24 weeks, 28 weeks, 32 weeks & 36 weeks of gestation | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin D & calcium levels, kidney function tests, liver function tests, lipid profile and cordblood vitamin D levelsTimepoint: Baseline & 36 weeks | — |
Countries
India
Contacts
BPS Govt. Medical College Khanpur Kalan, Sonipat